Pershing Square Sinks 12% on Second Downgrade in Two Days as BofA Cuts Target to $38
Pershing Square (PS) shares dropped 12% after BofA downgraded it to Underperform and cut its price target to $38 from $54, citing delayed PSV launch and reduced growth expectations. Citi also downgraded the stock to Sell, noting flat earnings estimates since its April IPO. The company's flagship fund's NAV fell 12.6% in H1 2026, underperforming the S&P 500's 10.2% gain.
How this was made
The 30-second read
Why it matters
Two back-to-back sell-side downgrades (Citi then BofA) shift the narrative from growth to peer-like valuation, driven by delayed PSV launch and weak flagship fund returns versus the S&P 500.
Market read
Valuation and earnings-estimate revisions for PSH are immediate, with investors focused on whether the flagship fund can re-accelerate returns before new funds justify the growth multiple.
What to watch
The article emphasizes NAV underperformance and estimate cuts, but does not quantify how quickly performance fees could recover once returns improve, which could cap downside if catalysts are near-term.
Background
Pershing Square Holdings is an asset manager whose valuation has been treated as a growth story since its April IPO, with expectations tied to new fund launches.
Ticker impact
Pershing Square Holdings shares fell 12% after BofA downgraded it to Underperform and cut its price target to $38 from $54.
Likely further downside or choppy trading as investors wait for a firmer PSV launch timeline and improved flagship NAV/returns.
The article ties the downgrade and target cut to specific, time-sensitive drivers: delayed PSV launch, lower earnings estimates, and underperformance of the flagship fund versus the S&P 500.
Market effects
Adds to scrutiny of asset managers’ growth narratives when fund performance lags and new-product launch timing slips.
Primarily US-listed asset-manager sentiment, with read-through to other performance-fee models.
Limited direct global spillover, but reinforces global investor preference for near-term earnings visibility.
Counterpoint
If PSV launch timing normalizes and flagship returns rebound, the market may over-discount the delayed growth multiple implied by the $38 target.
Key entities
- companyPershing Square Holdings
Subject of the downgrades and price-target cut; shares sank 12% on the news.
- analyst_firmBofA
Downgraded to Underperform and cut price target to $38 from $54, citing delayed PSV launch and lower earnings estimates.
- analyst_firmCiti
Previously downgraded to Sell, arguing earnings estimates have barely moved since the April IPO.
